SHANGHAI and BOSTON, April 17, 2025 /PRNewswire/ -- VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a robust discovery and development platform of multi-specific antibodies and antibody-drug conjugate (ADC), today announced its second...
Read More Details
Finally We wish PressBee provided you with enough information of ( VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model )
Also on site :
- Walmart Is Selling a 'Fantastic' $400 Charcoal Smoker Grill for Just $110, and Shoppers Say It's 'Perfect for Tailgating and Picnics'
- Orlando Bloom Spotted With Kim Kardashian Amid Katy Perry Split Rumors
- 'General Hospital' Legend, 62, Makes Rare Red Carpet Appearance To Honor Late Co-Star